CIAS
TMO icon

Capital Investment Advisory Services’s Thermo Fisher Scientific TMO Stock Holding History

Capital Investment Advisory Services’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$485K Buy
968
+13
+1% +$6.24K 0.03% 449
2026
Q1 		$470K Buy
955
+14
+1% +$7.6K 0.03% 407
2025
Q4 		$545K Sell
941
-24
-2% -$13.6K 0.04% 367
2025
Q3 		$468K Buy
965
+16
+2% +$7.45K 0.04% 379
2025
Q2 		$385K Sell
949
-25
-3% -$10.5K 0.03% 397
2025
Q1 		$485K Sell
974
-115
-11% -$62.3K 0.04% 330
2024
Q4 		$567K Hold
1,089
– – 0.05% 266
2024
Q3 		$674K Sell
1,089
-10
-0.9% -$5.92K 0.06% 250
2024
Q2 		$608K Sell
1,099
-12
-1% -$6.88K 0.06% 256
2024
Q1 		$646K Buy
1,111
+10
+0.9% +$5.61K 0.07% 255
2023
Q4 		$584K Sell
1,101
-25
-2% -$12.1K 0.05% 261
2023
Q3 		$570K Sell
1,126
-293
-21% -$156K 0.06% 258
2023
Q2 		$740K Sell
1,419
-77
-5% -$41.6K 0.07% 221
2023
Q1 		$862K Sell
1,496
-492
-25% -$277K 0.1% 181
2022
Q4 		$1.09M Buy
1,988
+40
+2% +$21.2K 0.13% 152
2022
Q3 		$988K Sell
1,948
-61
-3% -$34.1K 0.13% 144
2022
Q2 		$1.09M Buy
2,009
+3
+0.1% +$1.65K 0.13% 145
2022
Q1 		$1.19M Buy
2,006
+23
+1% +$13.2K 0.13% 146
2021
Q4 		$1.32M Buy
1,983
+9
+0.5% +$5.62K 0.16% 137
2021
Q3 		$1.13M Buy
1,974
+1
+0.1% +$549 0.14% 143
2021
Q2 		$995K Sell
1,973
-75
-4% -$35.4K 0.13% 161
2021
Q1 		$935K Sell
2,048
-90
-4% -$43K 0.13% 162
2020
Q4 		$996K Buy
2,138
+169
+9% +$79.2K 0.15% 145
2020
Q3 		$869K Buy
1,969
+213
+12% +$88K 0.16% 131
2020
Q2 		$636K Sell
1,756
-14
-0.8% -$4.69K 0.13% 148
2020
Q1 		$502K Buy
1,770
+97
+6% +$30.6K 0.12% 157
2019
Q4 		$544K Buy
1,673
+35
+2% +$10.6K 0.15% 153
2019
Q3 		$477K Buy
1,638
+20
+1% +$5.73K 0.13% 153
2019
Q2 		$472K Buy
1,618
+1,426
+743% +$393K 0.14% 150
2019
Q1 		$53K Buy
192
+35
+22% +$8.71K 0.02% 472
2018
Q4 		$35K Buy
+157
New +$36.8K 0.01% 535

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Capital Investment Advisory Services's TMO Position: Q2 2026 in Review

Capital Investment Advisory Services increased its Thermo Fisher Scientific (TMO) stake by 1.4% in Q2 2026, buying an estimated $6.24K and bringing the position to 968 shares worth $485K. The position accounts for 0.03% of the portfolio, ranked #449.

Capital Investment Advisory Services first reported a position in TMO in Q4 2018 and has held it in 31 quarters since. The position peaked at $1.32M in Q4 2021. 2,215 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Capital Investment Advisory Services held 968 shares of Thermo Fisher Scientific worth $485K as of Q2 2026.
  • Capital Investment Advisory Services bought 13 Thermo Fisher Scientific shares in Q2 2026, an estimated $6.24K.
  • Thermo Fisher Scientific made up 0.03% of Capital Investment Advisory Services's portfolio in Q2 2026, its #449 holding.
  • Capital Investment Advisory Services first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 31 quarters since.
  • Capital Investment Advisory Services's Thermo Fisher Scientific position peaked at $1.32M in Q4 2021.
  • 2,215 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Capital Investment Advisory Services's 13F filing for Q2 2026, filed 23 Jul 2026.